Arthur He
Stock Analyst at HC Wainwright & Co.
(3.26)
# 1,205
Out of 4,479 analysts
43
Total ratings
42.86%
Success rate
4.17%
Average return
Main Sectors:
Top Industries:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADAG Adagene | Reiterates: Buy | n/a | $2.99 | - | 6 | Jun 28, 2024 | |
| LVTX LAVA Therapeutics | Reiterates: Buy | $6 | $1.87 | +220.86% | 7 | Jun 28, 2024 | |
| HOOK HOOKIPA Pharma | Maintains: Buy | $5 → $6 | $0.58 | +931.64% | 6 | Jun 5, 2024 | |
| CALT Calliditas Therapeutics AB (publ) | Downgrades: Neutral | $39 | $38.75 | +0.65% | 4 | May 28, 2024 | |
| PSTX Poseida Therapeutics | Reiterates: Buy | $20 | $3.02 | +562.25% | 10 | May 22, 2024 | |
| PRME Prime Medicine | Initiates: Buy | $10 | $5.28 | +89.39% | 1 | May 20, 2024 | |
| SLDB Solid Biosciences | Reiterates: Buy | $16 | $5.96 | +168.46% | 3 | May 20, 2024 | |
| BCAB BioAtla | Reiterates: Buy | $7 | $1.32 | +430.30% | 6 | May 15, 2024 |
Adagene
Jun 28, 2024
Reiterates: Buy
Price Target: n/a
Current: $2.99
Upside: -
LAVA Therapeutics
Jun 28, 2024
Reiterates: Buy
Price Target: $6
Current: $1.87
Upside: +220.86%
HOOKIPA Pharma
Jun 5, 2024
Maintains: Buy
Price Target: $5 → $6
Current: $0.58
Upside: +931.64%
Calliditas Therapeutics AB (publ)
May 28, 2024
Downgrades: Neutral
Price Target: $39
Current: $38.75
Upside: +0.65%
Poseida Therapeutics
May 22, 2024
Reiterates: Buy
Price Target: $20
Current: $3.02
Upside: +562.25%
Prime Medicine
May 20, 2024
Initiates: Buy
Price Target: $10
Current: $5.28
Upside: +89.39%
Solid Biosciences
May 20, 2024
Reiterates: Buy
Price Target: $16
Current: $5.96
Upside: +168.46%
BioAtla
May 15, 2024
Reiterates: Buy
Price Target: $7
Current: $1.32
Upside: +430.30%